Engineers use 'DNA origami' to identify vaccine design rules

Grantee News
June 30, 2020

Using DNA origami as a virus-like scaffold, researchers designed an HIV-like particle that provokes a strong response from human immune cells grown in the lab. They are now testing this approach as a potential vaccine candidate in live animals, and adapting it to SARS-CoV-2, as well as other pathogens. Read more from MIT News.

Health Tags
HIV
Infectious Diseases
Vaccines
Research Tags
Biomaterials
COVID-19
Drug Delivery Systems